You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Drug Formulary
About the Drug Formulary Email Drug Formulary Team

Financement des régimes fondés sur les données probantes

Les monographies et fiches d’information sur les médicaments et les régimes à l’intention des patients offrent des renseignements sur la posologie et l’administration des traitements contre le cancer.

Elles ne sont fournies qu’à titre indicatif et ne visent pas à remplacer les renseignements posologiques ni les recommandations d’un médecin.

Si vous avez des questions à propos du financement des TS-PBQ, veuillez consulter la Foire aux questions (anglais) de notre site Web.

Découvrez les fiches d’information améliorées sur les régimes à l’intention des patients, élaborées en collaboration avec les conseillers des patients et des familles. Disponible en français.

Regimens

Filtered By:
47 Items
Cancer Type: Breast     
Intent: Neoadjuvant, Adjuvant
Funding:
New Drug Funding Program
    Docetaxel - FEC-D or AC-DOCE for Adjuvant Treatment for Breast Cancer
New Drug Funding Program
    Docetaxel - Neoadjuvant treatment for Non-Metastatic Breast Cancer
New Drug Funding Program
    Trastuzumab (Biosimilar) - Adjuvant Treatment for Breast Cancer
Evidence Building Program
    Trastuzumab (EBP) - Adjuvant Treatment for Breast Cancer
Evidence Building Program
    Trastuzumab (EBP) - Adjuvant Treatment for Breast Cancer Supplemental
... Show more tags
Drugs Used:
DOXOrubicin,
cyclophosphamide,
DOCEtaxel,
trastuzumab
... Show more tags
Quick Link(s):
Regimen Monograph
Dec 2019
Cancer Type: Breast     
Intent: Palliative
Funding:
ODB - General Benefit
    capecitabine
New Drug Funding Program
    Docetaxel - Metastatic Breast Cancer
... Show more tags
Drugs Used:
DOCEtaxel,
capecitabine
... Show more tags
Quick Link(s):
Regimen Monograph, Patient Info Sheet
May 2019
Cancer Type: Lung, Non-Small Cell     
Intent: Palliative
Funding:
New Drug Funding Program
    Docetaxel - Non-Small Cell Lung Cancer (NSCLC)
... Show more tags
Drugs Used:
DOCEtaxel,
CISplatin
... Show more tags
Quick Link(s):
Regimen Monograph, Patient Info Sheet
Feb 2017
Cancer Type: Head and Neck     
Intent: Palliative
Drugs Used:
DOCEtaxel,
CISplatin
... Show more tags
Quick Link(s):
Regimen Monograph
Oct 2017
Cancer Type: Head and Neck     
Intent: Neoadjuvant
Drugs Used:
DOCEtaxel,
CISplatin,
fluorouracil
... Show more tags
Quick Link(s):
Regimen Monograph
Feb 2017
Cancer Type: Gastrointestinal, Anus     
Intent: Palliative
Drugs Used:
DOCEtaxel,
CISplatin,
fluorouracil
... Show more tags
Quick Link(s):
Regimen Monograph
Jun 2019
Cancer Type: Lung, Non-Small Cell     
Intent: Palliative
Funding:
New Drug Funding Program
    Docetaxel - Non-Small Cell Lung Cancer (NSCLC)
... Show more tags
Drugs Used:
DOCEtaxel,
CARBOplatin
... Show more tags
Quick Link(s):
Regimen Monograph
May 2019
Cancer Type: Gynecologic, Ovary     
Intent: Adjuvant
Drugs Used:
DOCEtaxel,
CARBOplatin
... Show more tags
Quick Link(s):
Regimen Monograph
Jun 2019
Cancer Type: Gynecologic, Ovary     
Intent: Palliative
Drugs Used:
DOCEtaxel,
CARBOplatin
... Show more tags
Quick Link(s):
Regimen Monograph
Jun 2019
Cancer Type: Breast     
Intent: Curative, Adjuvant
Funding:
New Drug Funding Program
    Trastuzumab - Adjuvant Treatment for HER2_neu-Overexpressing Primary Breast Cancer
... Show more tags
Drugs Used:
DOCEtaxel,
CARBOplatin,
PERTuzumab (Unfunded),
trastuzumab
... Show more tags
Quick Link(s):
Regimen Monograph
Nov 2019
Cancer Type: Breast     
Intent: Neoadjuvant, Adjuvant
Funding:
New Drug Funding Program
    Trastuzumab (Biosimilar) - Adjuvant Treatment for Breast Cancer
Evidence Building Program
    Trastuzumab (EBP) - Adjuvant Treatment for Breast Cancer
... Show more tags
Drugs Used:
DOCEtaxel,
CARBOplatin,
trastuzumab
... Show more tags
Quick Link(s):
Regimen Monograph
Dec 2019
Cancer Type: Hematologic, Multiple Myeloma     
Intent: Palliative
Funding:
ODB - General Benefit
    cyclophosphamide - oral tablets
ODB - General Benefit
    dexamethasone
... Show more tags
Drugs Used:
cyclophosphamide,
dexamethasone,
thalidomide (Unfunded)
... Show more tags
Quick Link(s):
Regimen Monograph
Sep 2019